Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Malignant Lymphoma

  Free Subscription


25.05.2026

3 Am J Hematol
1 Blood
1 BMC Neurol
1 Br J Haematol
1 Eur J Haematol
2 Haematologica
1 J Am Acad Dermatol
3 Leuk Lymphoma
2 Mod Pathol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. DONGLU Z, Yuqin S, Jiayue Q, Hongyan T, et al
    Mutation Profiling, Efficacy Monitoring, and Prognosis Evaluation Using Circulating Tumor DNA in Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Observational Study.
    Am J Hematol. 2026 May 21. doi: 10.1002/ajh.70357.
    PubMed        

  2. BOUILLE F, Baron M, Houot R, Chapelle R, et al
    CAR T-Cell Therapy in Patients With Primary Central Nervous System Lymphoma: A LOC Network Study.
    Am J Hematol. 2026 May 17. doi: 10.1002/ajh.70375.
    PubMed        

  3. CASTILLO JJ, Beltran BE, Florindez JA, Chavez JC, et al
    Plasmablastic Lymphoma: 2026 Update on Diagnosis, Risk Stratification, and Management.
    Am J Hematol. 2026 May 15. doi: 10.1002/ajh.70373.
    PubMed         Abstract available


    Blood

  4. HU S, Qin Y, Yi HM, Huang YH, et al
    N6-methyladenosine reader IGF2BP2 in T-cell lymphoma.
    Blood. 2026 May 21:blood.2026034186. doi: 10.1182/blood.2026034186.
    PubMed         Abstract available


    BMC Neurol

  5. ISHIKAWA M, Watanabe H, Nakashima H, Ozawa T, et al
    Methotrexate-induced myelopathy: a great imitator of relapsed malignant lymphoma.
    BMC Neurol. 2026 May 20. doi: 10.1186/s12883-026-04977.
    PubMed         Abstract available


    Br J Haematol

  6. GOODALL E, Palmer J, Martynchyk A, Waters N, et al
    Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice.
    Br J Haematol. 2026 May 15. doi: 10.1111/bjh.70550.
    PubMed         Abstract available


    Eur J Haematol

  7. VIERBOOM L, Loh AHP
    Updates in Evidence-Based Decision Making for Upfront Surgical Interventions in Paediatric Lymphoma.
    Eur J Haematol. 2026 May 20. doi: 10.1111/ejh.70229.
    PubMed         Abstract available


    Haematologica

  8. AHEARNE MJ
    An epigenetic Achilles' heel in extranodal NK/T-cell lymphoma?
    Haematologica. 2026 May 21. doi: 10.3324/haematol.2026.301083.
    PubMed         Abstract available

  9. SESQUES P, Houot R, Al Tabaa Y, Le Bras F, et al
    Prolonged survival with glofitamab in non-diffuse large B-cell lymphoma after CAR T-cell therapy relapse.
    Haematologica. 2026 May 21. doi: 10.3324/haematol.2026.300537.
    PubMed         Abstract available


    J Am Acad Dermatol

  10. WANG JY, Zeitouni N, Austin E, Jagdeo J, et al
    Photodynamic therapy: Clinical applications in dermatology.
    J Am Acad Dermatol. 2026;94:1635-1650.
    PubMed         Abstract available


    Leuk Lymphoma

  11. WOBSER M, Rosenwald A, Eisele F, Maurus K, et al
    Second-line treatment with tafasitamab and lenalidomide for relapsed/refractory primary cutaneous diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2026 May 22:1-4. doi: 10.1080/10428194.2026.2672106.
    PubMed        

  12. QU M, Ni T, Wu P
    The risk and predictors of second primary malignancies in survivors of angioimmunoblastic T-cell lymphoma: a population-based competing risk analysis.
    Leuk Lymphoma. 2026 May 22:1-13. doi: 10.1080/10428194.2026.2665246.
    PubMed         Abstract available

  13. SAHA A, Jhaveri K, Perini GF, Chavez JC, et al
    From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy.
    Leuk Lymphoma. 2026 May 19:1-13. doi: 10.1080/10428194.2026.2662494.
    PubMed         Abstract available


    Mod Pathol

  14. BLEDSOE JR, Ferry JA, Li J, Sassoon A, et al
    Recurrent SWI/SNF Deficiency Defines a Subset of Peripheral T-cell Lymphoma With Distinct Clinicopathologic Features.
    Mod Pathol. 2026 May 19:101015. doi: 10.1016/j.modpat.2026.101015.
    PubMed         Abstract available

  15. ORTIZ REQUENA D, Montgomery EA, Ronquillo NR, Garcia-Buitrago M, et al
    Multiple Myeloma and Mimicry: Gastrointestinal Tract Histologic Findings in Patients Following Chimeric Antigen Receptor T-cell Therapy and Anti-CD38 Monoclonal Antibodies.
    Mod Pathol. 2026;39:100991.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum